Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Finished Goods: 2018-2019

Historic Finished Goods for Niagen Bioscience (NAGE) over the last 2 years, with Dec 2019 value amounting to $4.9 million.

  • Niagen Bioscience's Finished Goods rose 99.06% to $4.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.9 million, marking a year-over-year increase of 99.06%. This contributed to the annual value of $4.9 million for FY2019, which is 99.06% up from last year.
  • According to the latest figures from FY2019, Niagen Bioscience's Finished Goods is $4.9 million, which was up 99.06% from $2.5 million recorded in FY2018.
  • Niagen Bioscience's Finished Goods' 5-year high stood at $4.9 million during FY2019, with a 5-year trough of $2.5 million in FY2018.
  • For the 2-year period, Niagen Bioscience's Finished Goods averaged around $3.7 million, with its median value being $3.7 million (2018).
  • Data for Niagen Bioscience's Finished Goods shows a peak YoY skyrocketed of 99.06% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Niagen Bioscience's Finished Goods stood at $2.5 million in 2018, then skyrocketed by 99.06% to $4.9 million in 2019.